TERT Promoter Mutations in Thyroid Cancer
Two mutations (C228T and C250T) in the promoter region of the telomerase reverse
transcriptase (TERT) have recently been described in different types of cancer including …
transcriptase (TERT) have recently been described in different types of cancer including …
Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability
S Hong, Y Xie, Z Cheng, J Li, W He, Z Guo, Q Zhang… - Oncogene, 2022 - nature.com
Papillary thyroid carcinoma (PTC) is heterogeneous and its molecular characteristics remain
elusive. We integrated transcriptomic sequencing, genomic analysis and clinicopathologic …
elusive. We integrated transcriptomic sequencing, genomic analysis and clinicopathologic …
[HTML][HTML] Signaling pathways in thyroid cancer and their therapeutic implications
S Jin, O Borkhuu, W Bao, YT Yang - Journal of clinical medicine …, 2016 - ncbi.nlm.nih.gov
Thyroid cancer is a common malignancy of endocrine system, and has now become the
fastest increasing cancer among all the malignancies. The development, progression …
fastest increasing cancer among all the malignancies. The development, progression …
Controversies in the management of low-risk differentiated thyroid cancer
MR Haymart, NH Esfandiari, MT Stang… - Endocrine …, 2017 - academic.oup.com
Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management, including surgery, use of radioactive …
controversy occurs in all aspects of management, including surgery, use of radioactive …
Rising incidence and incidence-based mortality of thyroid cancer in California, 2000-2017
Context The increased incidence of thyroid cancer globally over the past several decades is
principally attributed to small, indolent papillary thyroid cancers. A possible concomitant …
principally attributed to small, indolent papillary thyroid cancers. A possible concomitant …
ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome
C Tavares, M Melo… - European journal of …, 2016 - academic.oup.com
Genetic predictors of outcome are reviewed in the context of a disease–cancer–that can be
(too) simplistically described as a 'successful, invasive clone of our own tissues'. Context has …
(too) simplistically described as a 'successful, invasive clone of our own tissues'. Context has …
A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma
HG Vuong, UNP Duong, AMA Altibi… - Endocrine …, 2017 - ec.bioscientifica.com
The prognostic role of molecular markers in papillary thyroid carcinoma (PTC) is a matter of
ongoing debate. The aim of our study is to investigate the impact of RAS, BRAF, TERT …
ongoing debate. The aim of our study is to investigate the impact of RAS, BRAF, TERT …
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment
Background Precise risk stratification-based treatment of solitary intrathyroidal papillary
thyroid cancer (SI-PTC) that is larger than 1.0 cm and 4.0 cm or less is undefined. Methods A …
thyroid cancer (SI-PTC) that is larger than 1.0 cm and 4.0 cm or less is undefined. Methods A …
[HTML][HTML] BRAF V600E confers male sex disease-specific mortality risk in patients with papillary thyroid cancer
BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary
Thyroid Cancer - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
Thyroid Cancer - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
Influence of nomenclature changes on trends in papillary thyroid cancer incidence in the United States, 2000 to 2017
Context US papillary thyroid carcinoma (PTC) incidence recently declined for the first time in
decades, for reasons that remain unclear. Objective This work aims to evaluate PTC …
decades, for reasons that remain unclear. Objective This work aims to evaluate PTC …